Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$3.69B |
| 2 |
Abbott
ABT
|
+$3.65B |
| 3 |
Qualcomm
QCOM
|
+$3.54B |
| 4 |
Procter & Gamble
PG
|
+$3.42B |
| 5 |
Accenture
ACN
|
+$3.28B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$2.86B |
| 2 |
AbbVie
ABBV
|
+$2.71B |
| 3 |
Valero Energy
VLO
|
+$1.86B |
| 4 |
Lockheed Martin
LMT
|
+$916M |
| 5 |
Halliburton
HAL
|
+$856M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 10.68% |
| 3 | Healthcare | 10.19% |
| 4 | Industrials | 8.63% |
| 5 | Consumer Discretionary | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
EverQuote
EVER
$886M
| $3.46M | ﹤0.01% |
224,707
-7,224
| -3% | -$137K |
|
|
YSS
2552
York Space Systems
YSS
$2.24B
| $3.46M | ﹤0.01% |
+156,290
| New | +$3.79M |
|
2553
CryoPort
CYRX
$775M
| $3.46M | ﹤0.01% |
417,564
-11,611
| -3% | -$105K |
|
|
HNGE
2554
Hinge Health
HNGE
$5.75B
| $3.46M | ﹤0.01% |
89,658
+1,474
| +2% | +$61.3K |
|
2555
Teekay
TK
$975M
| $3.43M | ﹤0.01% |
281,083
+70,610
| +34% | +$779K |
|
|
KMTS
2556
Kestra Medical Technologies
KMTS
$1.23B
| $3.43M | ﹤0.01% |
172,174
+52,568
| +44% | +$1.24M |
|
2557
Genmab
GMAB
$17.7B
| $3.42M | ﹤0.01% |
127,571
+16,772
| +15% | +$503K |
|
2558
Bioventus
BVS
$799M
| $3.41M | ﹤0.01% |
373,942
-1,231
| -0.3% | -$10.3K |
|
2559
Allogene Therapeutics
ALLO
$601M
| $3.41M | ﹤0.01% |
1,396,533
+40,724
| +3% | +$81.6K |
|
2560
Custom Truck One Source
CTOS
$2.47B
| $3.4M | ﹤0.01% |
517,411
+12,527
| +2% | +$82.3K |
|
2561
State Street SPDR Portfolio Europe ETF
SPEU
$712M
| $3.39M | ﹤0.01% |
66,118
-1,886
| -3% | -$101K |
|
|
FSUN
2562
FirstSun Capital Bancorp
FSUN
$1.61B
| $3.38M | ﹤0.01% |
92,756
-4,254
| -4% | -$161K |
|
2563
Riley Exploration Permian
REPX
$770M
| $3.38M | ﹤0.01% |
92,716
-5,804
| -6% | -$173K |
|
2564
Smith & Nephew
SNN
$12.9B
| $3.36M | ﹤0.01% |
105,591
+37,819
| +56% | +$1.29M |
|
|
AEVA
2565
Aeva Technologies
AEVA
$1.02B
| $3.35M | ﹤0.01% |
254,195
-3,316
| -1% | -$49.3K |
|
2566
Thryv Holdings
THRY
$169M
| $3.34M | ﹤0.01% |
1,220,276
+67,386
| +6% | +$265K |
|
2567
Atlanticus Holdings
ATLC
$1.5B
| $3.34M | ﹤0.01% |
63,685
-1,470
| -2% | -$82.2K |
|
2568
Tenaris
TS
$29.1B
| $3.34M | ﹤0.01% |
57,342
+5,558
| +11% | +$274K |
|
2569
Portillo's
PTLO
$315M
| $3.34M | ﹤0.01% |
630,579
-12,714
| -2% | -$69.2K |
|
2570
OneSpan
OSPN
$562M
| $3.31M | ﹤0.01% |
314,462
-518
| -0.2% | -$5.88K |
|
|
MPLT
2571
MapLight Therapeutics
MPLT
$1.66B
| $3.28M | ﹤0.01% |
161,146
+22,719
| +16% | +$406K |
|
2572
Fulcrum Therapeutics
FULC
$248M
| $3.27M | ﹤0.01% |
426,869
+37,973
| +10% | +$352K |
|
2573
Regenxbio
RGNX
$623M
| $3.27M | ﹤0.01% |
390,601
-860
| -0.2% | -$9.04K |
|
2574
Bowman Consulting
BWMN
$454M
| $3.27M | ﹤0.01% |
114,987
-3,607
| -3% | -$118K |
|
2575
Logitech
LOGI
$15.2B
| $3.27M | ﹤0.01% |
35,871
+5,957
| +20% | +$549K |
|
Similar funds
Charles Schwab's Q1 2026 Portfolio in Review
As of Q1 2026, Charles Schwab held 3,535 positions worth $654B, up 1.7% from $644B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Charles Schwab deployed $21.4B of net new capital in Q1 2026, opening 79 new positions and adding to 1,903 existing holdings. Its largest new stake was JPMorgan Income ETF: 8,679,689 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Cisco, an estimated $2.86B trimmed.
- Charles Schwab's largest Q1 2026 buy was JPMorgan Income ETF: 8,679,689 shares worth $400M.
- Charles Schwab added most to UnitedHealth in Q1 2026, an estimated $3.69B increase.
- Charles Schwab's biggest Q1 2026 reduction was Cisco, cutting an estimated $2.86B.
- Charles Schwab fully exited Comerica in Q1 2026, selling an estimated $412M.
- Charles Schwab's ten largest holdings make up 22% of its $654B portfolio in Q1 2026.
- Charles Schwab opened 79 new positions and closed 80 in Q1 2026.
- Charles Schwab's portfolio value rose 1.7% quarter-over-quarter to $654B.
Based on Charles Schwab's 13F filing for Q1 2026, filed 15 May 2026.